Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Autobytel Inc.
Autobytel and Edmunds Enter Settlement Agreement
April 4th, 2009
Autobytel Inc. (Nasdaq: ABTL) and Edmunds.com, Inc. announced that they entered into a settlement resolving Edmunds’ declaratory judgment action (Edmunds Holding Company and Edmunds.com, Inc. v. Autobytel Inc.) filed against Autobytel in the U.S. District Court for the District of Delaware and relating to Autobytel’s U.S. Patent Number 6,282,517 for lead technology (“’517 Patent”). Although the case was recently dismissed by the court, the parties have entered into a settlement to avoid any further proceedings in this matter. According to the settlement, Autobytel has granted to Edmunds a limited license to the ’517 Patent and other existing Autobytel leads-related...
Source: Law & Health Weekly (2009-04-04)
|
